| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kv1.3 Potassium Channel | 30 | 2023 | 36 | 4.200 |
Why?
|
| Potassium Channel Blockers | 27 | 2023 | 83 | 3.430 |
Why?
|
| Arthritis, Rheumatoid | 12 | 2023 | 260 | 2.220 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 8 | 2019 | 23 | 1.900 |
Why?
|
| Autoimmune Diseases | 10 | 2023 | 251 | 1.670 |
Why?
|
| Peptides | 14 | 2023 | 792 | 1.650 |
Why?
|
| T-Lymphocytes | 26 | 2019 | 1709 | 1.560 |
Why?
|
| Cnidarian Venoms | 9 | 2015 | 10 | 1.430 |
Why?
|
| Hypersensitivity, Delayed | 9 | 2017 | 35 | 1.350 |
Why?
|
| Scorpion Venoms | 9 | 2018 | 13 | 1.320 |
Why?
|
| Rats | 32 | 2023 | 3674 | 1.260 |
Why?
|
| Potassium Channels, Voltage-Gated | 10 | 2007 | 59 | 1.260 |
Why?
|
| Immunologic Memory | 13 | 2020 | 188 | 1.170 |
Why?
|
| Ion Channels | 5 | 2018 | 191 | 1.120 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 9 | 2012 | 33 | 1.040 |
Why?
|
| Dependovirus | 2 | 2023 | 127 | 0.930 |
Why?
|
| Matrix Metalloproteinases | 2 | 2017 | 66 | 0.880 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2017 | 313 | 0.880 |
Why?
|
| Animals | 57 | 2025 | 33999 | 0.740 |
Why?
|
| Sea Anemones | 4 | 2015 | 5 | 0.700 |
Why?
|
| Rats, Inbred Lew | 16 | 2019 | 68 | 0.690 |
Why?
|
| Probiotics | 1 | 2023 | 214 | 0.670 |
Why?
|
| Cell Movement | 5 | 2016 | 832 | 0.630 |
Why?
|
| Killer Cells, Natural | 2 | 2013 | 323 | 0.610 |
Why?
|
| Cell Separation | 3 | 2007 | 227 | 0.560 |
Why?
|
| Intermediate-Conductance Calcium-Activated Potassium Channels | 5 | 2013 | 14 | 0.550 |
Why?
|
| Myoblasts, Skeletal | 1 | 2016 | 12 | 0.540 |
Why?
|
| Spinal Cord | 2 | 2007 | 300 | 0.500 |
Why?
|
| Polyethylene Glycols | 1 | 2017 | 224 | 0.500 |
Why?
|
| Antirheumatic Agents | 1 | 2017 | 125 | 0.490 |
Why?
|
| Flow Cytometry | 5 | 2016 | 795 | 0.470 |
Why?
|
| Synoviocytes | 4 | 2019 | 4 | 0.470 |
Why?
|
| Fibroblasts | 7 | 2022 | 875 | 0.460 |
Why?
|
| Potassium Channels | 7 | 2004 | 157 | 0.450 |
Why?
|
| Multiple Sclerosis | 6 | 2011 | 330 | 0.440 |
Why?
|
| Cells, Cultured | 11 | 2019 | 3028 | 0.430 |
Why?
|
| Disease Models, Animal | 10 | 2018 | 4334 | 0.430 |
Why?
|
| Models, Molecular | 9 | 2015 | 1069 | 0.430 |
Why?
|
| Th2 Cells | 1 | 2014 | 183 | 0.420 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2013 | 263 | 0.410 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2020 | 195 | 0.400 |
Why?
|
| Spleen | 2 | 2017 | 281 | 0.400 |
Why?
|
| Mice | 24 | 2025 | 17584 | 0.370 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2010 | 19 | 0.360 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1699 | 0.360 |
Why?
|
| Cell Line | 13 | 2017 | 2734 | 0.350 |
Why?
|
| Ovalbumin | 5 | 2017 | 318 | 0.350 |
Why?
|
| Adjuvants, Immunologic | 3 | 2007 | 381 | 0.340 |
Why?
|
| Interleukin-2 | 3 | 2007 | 225 | 0.340 |
Why?
|
| Synovial Membrane | 3 | 2015 | 27 | 0.340 |
Why?
|
| Cell Differentiation | 2 | 2016 | 1889 | 0.330 |
Why?
|
| Patch-Clamp Techniques | 8 | 2018 | 281 | 0.330 |
Why?
|
| Protein Conformation | 9 | 2015 | 830 | 0.330 |
Why?
|
| Arthritis, Experimental | 3 | 2019 | 15 | 0.330 |
Why?
|
| Receptors, CCR7 | 7 | 2014 | 20 | 0.320 |
Why?
|
| Lymphocyte Activation | 9 | 2014 | 690 | 0.310 |
Why?
|
| Ion Channel Gating | 4 | 2013 | 123 | 0.300 |
Why?
|
| Kv1.1 Potassium Channel | 5 | 2015 | 36 | 0.290 |
Why?
|
| Hemocyanins | 1 | 2007 | 27 | 0.290 |
Why?
|
| Freund's Adjuvant | 1 | 2007 | 26 | 0.280 |
Why?
|
| Punctures | 1 | 2007 | 55 | 0.280 |
Why?
|
| Cell Division | 3 | 2007 | 776 | 0.280 |
Why?
|
| Biomedical Technology | 1 | 2007 | 36 | 0.280 |
Why?
|
| Saphenous Vein | 1 | 2007 | 60 | 0.280 |
Why?
|
| Blood Specimen Collection | 1 | 2007 | 49 | 0.280 |
Why?
|
| Amino Acid Sequence | 8 | 2015 | 2699 | 0.270 |
Why?
|
| Cell Membrane | 3 | 2016 | 460 | 0.270 |
Why?
|
| Humans | 41 | 2025 | 124143 | 0.270 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2007 | 141 | 0.270 |
Why?
|
| Asthma | 1 | 2014 | 742 | 0.260 |
Why?
|
| Up-Regulation | 2 | 2013 | 859 | 0.260 |
Why?
|
| Hepatocytes | 2 | 2025 | 207 | 0.250 |
Why?
|
| Calcium | 8 | 2018 | 1099 | 0.250 |
Why?
|
| Monocytes | 1 | 2007 | 350 | 0.250 |
Why?
|
| Matrix Metalloproteinase 2 | 3 | 2016 | 97 | 0.250 |
Why?
|
| Potassium Channels, Calcium-Activated | 1 | 2004 | 11 | 0.240 |
Why?
|
| Genes, Essential | 1 | 2025 | 40 | 0.230 |
Why?
|
| Calcium Channels | 3 | 2015 | 160 | 0.230 |
Why?
|
| Cell Adhesion | 2 | 2017 | 322 | 0.230 |
Why?
|
| Molecular Sequence Data | 6 | 2015 | 3872 | 0.230 |
Why?
|
| Gene Targeting | 1 | 2025 | 176 | 0.220 |
Why?
|
| Mutation | 1 | 2018 | 5818 | 0.220 |
Why?
|
| Demyelinating Diseases | 1 | 2004 | 64 | 0.220 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2015 | 1683 | 0.220 |
Why?
|
| Toxins, Biological | 2 | 2015 | 69 | 0.220 |
Why?
|
| Fluoresceins | 1 | 2003 | 35 | 0.210 |
Why?
|
| Electrophysiology | 5 | 2014 | 271 | 0.210 |
Why?
|
| Neurotoxins | 3 | 2015 | 56 | 0.210 |
Why?
|
| Fluorescent Dyes | 2 | 2008 | 261 | 0.200 |
Why?
|
| Heart | 1 | 2007 | 708 | 0.200 |
Why?
|
| Immunity, Innate | 2 | 2016 | 373 | 0.200 |
Why?
|
| Terpenes | 3 | 2017 | 28 | 0.200 |
Why?
|
| Gene Editing | 2 | 2025 | 187 | 0.200 |
Why?
|
| Syndecan-2 | 1 | 2022 | 9 | 0.190 |
Why?
|
| Cell Proliferation | 8 | 2016 | 2283 | 0.190 |
Why?
|
| TRPV Cation Channels | 2 | 2015 | 34 | 0.190 |
Why?
|
| Receptors, Chemokine | 3 | 2013 | 44 | 0.190 |
Why?
|
| Recombinant Proteins | 3 | 2015 | 1388 | 0.190 |
Why?
|
| Pulmonary Fibrosis | 1 | 2022 | 100 | 0.180 |
Why?
|
| Pancreatitis-Associated Proteins | 2 | 2013 | 10 | 0.180 |
Why?
|
| Lung Injury | 1 | 2022 | 123 | 0.170 |
Why?
|
| Inhibitory Concentration 50 | 3 | 2015 | 77 | 0.170 |
Why?
|
| Liver | 2 | 2025 | 1733 | 0.160 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2019 | 29 | 0.160 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2020 | 63 | 0.160 |
Why?
|
| Proteins | 3 | 2014 | 1035 | 0.160 |
Why?
|
| Brain | 2 | 2007 | 2977 | 0.150 |
Why?
|
| Immunosuppressive Agents | 3 | 2012 | 647 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2006 | 814 | 0.150 |
Why?
|
| Interleukin-10 | 2 | 2023 | 173 | 0.150 |
Why?
|
| Phenotype | 5 | 2018 | 4249 | 0.150 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2017 | 325 | 0.150 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2018 | 43 | 0.140 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 113 | 0.140 |
Why?
|
| Emulsions | 2 | 2007 | 69 | 0.140 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2014 | 288 | 0.140 |
Why?
|
| Integrin beta1 | 1 | 2017 | 53 | 0.140 |
Why?
|
| Arthritis | 2 | 2015 | 81 | 0.140 |
Why?
|
| Testicular Diseases | 1 | 2016 | 12 | 0.140 |
Why?
|
| Cell Fusion | 1 | 2016 | 37 | 0.130 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2015 | 341 | 0.130 |
Why?
|
| Immunomodulation | 1 | 2017 | 80 | 0.130 |
Why?
|
| Intracellular Space | 1 | 2016 | 48 | 0.130 |
Why?
|
| Inflammation | 2 | 2023 | 1423 | 0.130 |
Why?
|
| Antigens | 3 | 2007 | 155 | 0.130 |
Why?
|
| Kinetics | 3 | 2015 | 1321 | 0.130 |
Why?
|
| Female | 22 | 2019 | 66274 | 0.130 |
Why?
|
| Peptide Fragments | 3 | 2015 | 777 | 0.130 |
Why?
|
| Genetic Vectors | 1 | 2020 | 940 | 0.130 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2016 | 94 | 0.130 |
Why?
|
| Memory | 1 | 2019 | 362 | 0.130 |
Why?
|
| Learning | 1 | 2019 | 360 | 0.130 |
Why?
|
| Adoptive Transfer | 3 | 2007 | 237 | 0.130 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2023 | 700 | 0.120 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 352 | 0.120 |
Why?
|
| Time Factors | 4 | 2007 | 6281 | 0.120 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 573 | 0.120 |
Why?
|
| Disulfides | 2 | 2005 | 78 | 0.120 |
Why?
|
| Chromatography, Reverse-Phase | 1 | 2015 | 2 | 0.120 |
Why?
|
| Myelin Basic Protein | 3 | 2004 | 67 | 0.120 |
Why?
|
| Cystic Fibrosis | 1 | 2018 | 257 | 0.120 |
Why?
|
| Calcium Signaling | 2 | 2014 | 242 | 0.120 |
Why?
|
| Protein Stability | 2 | 2014 | 162 | 0.120 |
Why?
|
| Myotonic Dystrophy | 1 | 2016 | 149 | 0.120 |
Why?
|
| Antibody Formation | 1 | 2015 | 265 | 0.120 |
Why?
|
| Allergens | 1 | 2017 | 252 | 0.120 |
Why?
|
| Mutant Proteins | 1 | 2015 | 112 | 0.120 |
Why?
|
| Injections, Subcutaneous | 3 | 2017 | 127 | 0.120 |
Why?
|
| Gene Expression Regulation | 4 | 2022 | 2516 | 0.120 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2014 | 22 | 0.110 |
Why?
|
| NF-kappa B | 1 | 2016 | 450 | 0.110 |
Why?
|
| Interleukin-5 | 1 | 2014 | 43 | 0.110 |
Why?
|
| Protein Engineering | 2 | 2011 | 73 | 0.110 |
Why?
|
| Rats, Inbred F344 | 1 | 2014 | 105 | 0.110 |
Why?
|
| Drug Design | 1 | 2015 | 147 | 0.110 |
Why?
|
| Antioxidants | 1 | 2016 | 334 | 0.110 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2013 | 10 | 0.110 |
Why?
|
| Interleukin-4 | 1 | 2014 | 138 | 0.110 |
Why?
|
| Myocytes, Cardiac | 1 | 2018 | 603 | 0.110 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2014 | 149 | 0.110 |
Why?
|
| Helminths | 1 | 2014 | 45 | 0.110 |
Why?
|
| Nanoparticles | 1 | 2016 | 232 | 0.110 |
Why?
|
| Interleukin-13 | 1 | 2014 | 96 | 0.110 |
Why?
|
| Cell Degranulation | 1 | 2013 | 29 | 0.110 |
Why?
|
| K562 Cells | 1 | 2013 | 95 | 0.110 |
Why?
|
| Cytokines | 4 | 2023 | 1285 | 0.110 |
Why?
|
| Antibodies, Bacterial | 1 | 2015 | 388 | 0.110 |
Why?
|
| Neural Conduction | 2 | 2004 | 92 | 0.110 |
Why?
|
| Spinal Cord Injuries | 1 | 2016 | 311 | 0.110 |
Why?
|
| Interleukin-12 | 1 | 2013 | 114 | 0.100 |
Why?
|
| Immune Tolerance | 1 | 2014 | 143 | 0.100 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2015 | 167 | 0.100 |
Why?
|
| Immunity, Cellular | 1 | 2014 | 205 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2015 | 766 | 0.100 |
Why?
|
| Interleukin-15 | 1 | 2013 | 90 | 0.100 |
Why?
|
| Pichia | 1 | 2012 | 56 | 0.100 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 307 | 0.100 |
Why?
|
| Pyrazoles | 2 | 2013 | 305 | 0.100 |
Why?
|
| Thioredoxins | 1 | 2012 | 25 | 0.100 |
Why?
|
| Synovial Fluid | 1 | 2011 | 15 | 0.100 |
Why?
|
| Rheumatic Fever | 1 | 2011 | 18 | 0.090 |
Why?
|
| Young Adult | 2 | 2017 | 8990 | 0.090 |
Why?
|
| Obesity | 1 | 2023 | 2258 | 0.090 |
Why?
|
| Transgenes | 2 | 2025 | 334 | 0.090 |
Why?
|
| Shaker Superfamily of Potassium Channels | 1 | 2011 | 31 | 0.090 |
Why?
|
| Atrial Fibrillation | 1 | 2018 | 659 | 0.090 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2010 | 15 | 0.090 |
Why?
|
| Acrylic Resins | 1 | 2010 | 25 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2013 | 646 | 0.090 |
Why?
|
| Guinea Pigs | 4 | 2003 | 166 | 0.090 |
Why?
|
| Middle Aged | 6 | 2017 | 26587 | 0.080 |
Why?
|
| Rats, Wistar | 2 | 2017 | 359 | 0.080 |
Why?
|
| Immunologic Factors | 1 | 2011 | 174 | 0.080 |
Why?
|
| Binding, Competitive | 2 | 2012 | 185 | 0.080 |
Why?
|
| Neoplasms | 2 | 2014 | 2765 | 0.080 |
Why?
|
| Immunotherapy | 1 | 2014 | 665 | 0.080 |
Why?
|
| Adult | 6 | 2017 | 29339 | 0.080 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2007 | 125 | 0.080 |
Why?
|
| Ear, External | 1 | 2008 | 22 | 0.080 |
Why?
|
| Mice, Knockout | 3 | 2023 | 3720 | 0.080 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2008 | 38 | 0.080 |
Why?
|
| Antigen-Presenting Cells | 1 | 2008 | 117 | 0.070 |
Why?
|
| Shab Potassium Channels | 1 | 2007 | 2 | 0.070 |
Why?
|
| Purinergic P2 Receptor Antagonists | 1 | 2007 | 5 | 0.070 |
Why?
|
| NAV1.8 Voltage-Gated Sodium Channel | 1 | 2007 | 5 | 0.070 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 2007 | 3 | 0.070 |
Why?
|
| Concanavalin A | 1 | 2007 | 16 | 0.070 |
Why?
|
| HEK293 Cells | 3 | 2019 | 743 | 0.070 |
Why?
|
| Mitogens | 1 | 2007 | 31 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 2 | 2012 | 757 | 0.070 |
Why?
|
| Tissue Distribution | 2 | 2012 | 382 | 0.070 |
Why?
|
| Blood Cells | 1 | 2007 | 49 | 0.070 |
Why?
|
| Protein Structure, Secondary | 2 | 2005 | 237 | 0.070 |
Why?
|
| Injections, Intradermal | 1 | 2007 | 32 | 0.070 |
Why?
|
| Rats, Inbred Strains | 1 | 2007 | 232 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2016 | 1229 | 0.070 |
Why?
|
| Dermatitis | 1 | 2007 | 26 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2022 | 481 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 3151 | 0.070 |
Why?
|
| Sodium Channels | 1 | 2007 | 109 | 0.070 |
Why?
|
| Calcium Channel Blockers | 2 | 2004 | 115 | 0.070 |
Why?
|
| Immunization | 2 | 2020 | 307 | 0.070 |
Why?
|
| Structure-Activity Relationship | 3 | 2015 | 574 | 0.070 |
Why?
|
| Protein Binding | 3 | 2015 | 1737 | 0.060 |
Why?
|
| Optic Nerve | 2 | 2004 | 115 | 0.060 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2005 | 14 | 0.060 |
Why?
|
| RNA Interference | 2 | 2018 | 494 | 0.060 |
Why?
|
| Male | 10 | 2019 | 60992 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 3549 | 0.060 |
Why?
|
| Kv1.2 Potassium Channel | 1 | 2004 | 12 | 0.060 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 1 | 2004 | 13 | 0.060 |
Why?
|
| Hydrolases | 1 | 2025 | 54 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2018 | 658 | 0.060 |
Why?
|
| Synaptosomes | 1 | 2004 | 31 | 0.060 |
Why?
|
| Autoimmunity | 1 | 2005 | 171 | 0.060 |
Why?
|
| Sequence Analysis, Protein | 1 | 2004 | 49 | 0.060 |
Why?
|
| Static Electricity | 1 | 2004 | 44 | 0.060 |
Why?
|
| Furocoumarins | 1 | 2004 | 3 | 0.060 |
Why?
|
| Elapid Venoms | 1 | 2004 | 8 | 0.060 |
Why?
|
| Lymphocytes | 2 | 2004 | 406 | 0.060 |
Why?
|
| Action Potentials | 2 | 2004 | 500 | 0.060 |
Why?
|
| Gene Expression | 2 | 2020 | 1559 | 0.050 |
Why?
|
| Myelin Sheath | 1 | 2004 | 121 | 0.050 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2015 | 100 | 0.050 |
Why?
|
| Magnesium | 1 | 2023 | 120 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2007 | 1179 | 0.050 |
Why?
|
| Biotin | 1 | 2003 | 45 | 0.050 |
Why?
|
| Th17 Cells | 1 | 2023 | 89 | 0.050 |
Why?
|
| Anti-Citrullinated Protein Antibodies | 1 | 2022 | 3 | 0.050 |
Why?
|
| Citrullination | 1 | 2022 | 4 | 0.050 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 1 | 2022 | 7 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2003 | 471 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2025 | 4392 | 0.050 |
Why?
|
| Protein Kinase C | 1 | 2003 | 148 | 0.050 |
Why?
|
| Sp1 Transcription Factor | 1 | 2022 | 41 | 0.050 |
Why?
|
| Bleomycin | 1 | 2022 | 146 | 0.050 |
Why?
|
| DNA Repair | 1 | 2025 | 584 | 0.050 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2023 | 218 | 0.050 |
Why?
|
| Binding Sites | 2 | 2015 | 1293 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 1 | 2023 | 356 | 0.040 |
Why?
|
| Collagen | 2 | 2015 | 316 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2016 | 1585 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2004 | 1007 | 0.040 |
Why?
|
| COS Cells | 2 | 2012 | 275 | 0.040 |
Why?
|
| Gene Order | 1 | 2020 | 79 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2003 | 675 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 328 | 0.040 |
Why?
|
| Amino Acids | 1 | 2003 | 663 | 0.040 |
Why?
|
| Scorpions | 2 | 2012 | 4 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2020 | 329 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 2881 | 0.040 |
Why?
|
| Indenes | 1 | 2018 | 10 | 0.040 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2018 | 23 | 0.040 |
Why?
|
| Furans | 1 | 2018 | 28 | 0.040 |
Why?
|
| Sulfones | 1 | 2018 | 71 | 0.040 |
Why?
|
| Hypertrophy | 1 | 2018 | 102 | 0.040 |
Why?
|
| Language Development Disorders | 1 | 2019 | 174 | 0.040 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2018 | 196 | 0.040 |
Why?
|
| Isotope Labeling | 2 | 2012 | 104 | 0.040 |
Why?
|
| Dogs | 1 | 2018 | 767 | 0.040 |
Why?
|
| Arteries | 1 | 2018 | 220 | 0.040 |
Why?
|
| Aging | 1 | 2004 | 1165 | 0.030 |
Why?
|
| Inflammasomes | 1 | 2018 | 149 | 0.030 |
Why?
|
| Nanoconjugates | 1 | 2016 | 2 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2018 | 263 | 0.030 |
Why?
|
| Nanocapsules | 1 | 2016 | 7 | 0.030 |
Why?
|
| Cell Tracking | 1 | 2016 | 15 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2017 | 145 | 0.030 |
Why?
|
| Gadolinium DTPA | 1 | 2016 | 47 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2022 | 2389 | 0.030 |
Why?
|
| Cannabidiol | 1 | 2015 | 22 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 354 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2015 | 70 | 0.030 |
Why?
|
| Cannabinoids | 1 | 2015 | 31 | 0.030 |
Why?
|
| Oligopeptides | 1 | 2015 | 116 | 0.030 |
Why?
|
| Drosophila | 1 | 2019 | 782 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2015 | 229 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2016 | 2815 | 0.030 |
Why?
|
| Lung | 1 | 2022 | 1475 | 0.030 |
Why?
|
| Protein Subunits | 1 | 2014 | 164 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2016 | 1100 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2018 | 863 | 0.030 |
Why?
|
| Indoles | 1 | 2015 | 180 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 481 | 0.030 |
Why?
|
| Thermodynamics | 1 | 2013 | 142 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2014 | 406 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2014 | 657 | 0.030 |
Why?
|
| Metabolomics | 1 | 2016 | 421 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2018 | 4498 | 0.030 |
Why?
|
| Cancer Vaccines | 1 | 2014 | 177 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 2005 | 969 | 0.030 |
Why?
|
| Saimiri | 1 | 2012 | 11 | 0.030 |
Why?
|
| Absorption | 1 | 2012 | 52 | 0.030 |
Why?
|
| Chromatography, Affinity | 1 | 2012 | 70 | 0.020 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2012 | 43 | 0.020 |
Why?
|
| Nitrogen Isotopes | 1 | 2012 | 63 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 390 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 2012 | 87 | 0.020 |
Why?
|
| Amides | 1 | 2012 | 89 | 0.020 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2012 | 44 | 0.020 |
Why?
|
| Enzyme Precursors | 1 | 2011 | 22 | 0.020 |
Why?
|
| Gelatinases | 1 | 2011 | 14 | 0.020 |
Why?
|
| Phylogeny | 1 | 2014 | 696 | 0.020 |
Why?
|
| Protein Folding | 1 | 2012 | 216 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2011 | 3266 | 0.020 |
Why?
|
| DNA Primers | 1 | 2012 | 656 | 0.020 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2011 | 43 | 0.020 |
Why?
|
| Sunlight | 1 | 2011 | 23 | 0.020 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2011 | 22 | 0.020 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2011 | 11 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 3050 | 0.020 |
Why?
|
| Cholecalciferol | 1 | 2011 | 22 | 0.020 |
Why?
|
| CTLA-4 Antigen | 1 | 2011 | 52 | 0.020 |
Why?
|
| Glycosylation | 1 | 2011 | 119 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2011 | 209 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2011 | 307 | 0.020 |
Why?
|
| Vaccination | 1 | 2015 | 953 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 410 | 0.020 |
Why?
|
| Haplotypes | 1 | 2011 | 515 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2013 | 875 | 0.020 |
Why?
|
| Chlamydia trachomatis | 1 | 2008 | 25 | 0.020 |
Why?
|
| Xanthenes | 1 | 2008 | 7 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2011 | 420 | 0.020 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2011 | 257 | 0.020 |
Why?
|
| Orthomyxoviridae | 1 | 2008 | 50 | 0.020 |
Why?
|
| Chlamydia Infections | 1 | 2008 | 49 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2011 | 697 | 0.020 |
Why?
|
| Immunoconjugates | 1 | 2008 | 37 | 0.020 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2008 | 59 | 0.020 |
Why?
|
| Homeostasis | 1 | 2011 | 685 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2012 | 986 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2008 | 381 | 0.020 |
Why?
|
| Aged | 2 | 2016 | 19532 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 1607 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 3330 | 0.020 |
Why?
|
| Skin | 1 | 2008 | 517 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2011 | 1493 | 0.010 |
Why?
|
| Cnidaria | 1 | 2003 | 2 | 0.010 |
Why?
|
| CD3 Complex | 1 | 2003 | 86 | 0.010 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2003 | 47 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 324 | 0.010 |
Why?
|
| Thymidine | 1 | 2001 | 54 | 0.010 |
Why?
|
| Tritium | 1 | 2001 | 173 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1690 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2011 | 4780 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2001 | 24 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2001 | 78 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 6464 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2003 | 393 | 0.010 |
Why?
|
| Child | 1 | 2019 | 24356 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2001 | 676 | 0.010 |
Why?
|
| Risk Factors | 1 | 2011 | 10244 | 0.010 |
Why?
|